These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33883278)

  • 1. Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs.
    Saavedra-García P; Roman-Trufero M; Al-Sadah HA; Blighe K; López-Jiménez E; Christoforou M; Penfold L; Capece D; Xiong X; Miao Y; Parzych K; Caputo VS; Siskos AP; Encheva V; Liu Z; Thiel D; Kaiser MF; Piazza P; Chaidos A; Karadimitris A; Franzoso G; Snijders AP; Keun HC; Oyarzún DA; Barahona M; Auner HW
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33883278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibition in multiple myeloma: lessons for other cancers.
    Saavedra-García P; Martini F; Auner HW
    Am J Physiol Cell Physiol; 2020 Mar; 318(3):C451-C462. PubMed ID: 31875696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
    Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
    Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma.
    Ferguson ID; Lin YT; Lam C; Shao H; Tharp KM; Hale M; Kasap C; Mariano MC; Kishishita A; Patiño Escobar B; Mandal K; Steri V; Wang D; Phojanakong P; Tuomivaara ST; Hann B; Driessen C; Van Ness B; Gestwicki JE; Wiita AP
    Cell Chem Biol; 2022 Aug; 29(8):1288-1302.e7. PubMed ID: 35853457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons Learned from Proteasome Inhibitors, the Paradigm for Targeting Protein Homeostasis in Cancer.
    Kambhampati S; Wiita AP
    Adv Exp Med Biol; 2020; 1243():147-162. PubMed ID: 32297217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of stress-inducible HSP70 impairs mitochondrial proteostasis and function.
    Leu JI; Barnoud T; Zhang G; Tian T; Wei Z; Herlyn M; Murphy ME; George DL
    Oncotarget; 2017 Jul; 8(28):45656-45669. PubMed ID: 28484090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells.
    Thompson RM; Dytfeld D; Reyes L; Robinson RM; Smith B; Manevich Y; Jakubowiak A; Komarnicki M; Przybylowicz-Chalecka A; Szczepaniak T; Mitra AK; Van Ness BG; Luczak M; Dolloff NG
    Oncotarget; 2017 May; 8(22):35863-35876. PubMed ID: 28415782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-3-3ζ binds the proteasome, limits proteolytic function and enhances sensitivity to proteasome inhibitors.
    Gu Y; Xu K; Torre C; Samur M; Barwick BG; Rupji M; Arora J; Neri P; Kaufman J; Nooka A; Bernal-Mizrachi L; Vertino P; Sun SY; Chen J; Munshi N; Fu H; Kowalski J; Boise LH; Lonial S
    Leukemia; 2018 Mar; 32(3):744-751. PubMed ID: 28924240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome dysfunction induces excessive proteome instability and loss of mitostasis that can be mitigated by enhancing mitochondrial fusion or autophagy.
    Tsakiri EN; Gumeni S; Vougas K; Pendin D; Papassideri I; Daga A; Gorgoulis V; Juhász G; Scorrano L; Trougakos IP
    Autophagy; 2019 Oct; 15(10):1757-1773. PubMed ID: 31002009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma.
    Abdel Malek MA; Jagannathan S; Malek E; Sayed DM; Elgammal SA; Abd El-Azeem HG; Thabet NM; Driscoll JJ
    Oncotarget; 2015 Feb; 6(5):3098-110. PubMed ID: 25605012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma cells are exceptionally sensitive to heat shock, which overwhelms their proteostasis network and induces apoptosis.
    Sha Z; Goldberg AL
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21588-21597. PubMed ID: 32817432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling human protein degradome delineates cellular responses to proteasomal inhibition and reveals a feedback mechanism in regulating proteasome homeostasis.
    Yu T; Tao Y; Yang M; Chen P; Gao X; Zhang Y; Zhang T; Chen Z; Hou J; Zhang Y; Ruan K; Wang H; Hu R
    Cell Res; 2014 Oct; 24(10):1214-30. PubMed ID: 25223703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation.
    Parzych K; Saavedra-García P; Valbuena GN; Al-Sadah HA; Robinson ME; Penfold L; Kuzeva DM; Ruiz-Tellez A; Loaiza S; Holzmann V; Caputo V; Johnson DC; Kaiser MF; Karadimitris A; Lam EW; Chevet E; Feldhahn N; Keun HC; Auner HW
    Oncogene; 2019 Apr; 38(17):3216-3231. PubMed ID: 30626938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress.
    Kawaguchi T; Miyazawa K; Moriya S; Ohtomo T; Che XF; Naito M; Itoh M; Tomoda A
    Int J Oncol; 2011 Mar; 38(3):643-54. PubMed ID: 21174067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells.
    Skorda A; Sklirou AD; Sakellaropoulos T; Gianniou DD; Kastritis E; Terpos E; Tsitsilonis OE; Florea BI; Overkleeft HS; Dimopoulos MA; Alexopoulos LG; Trougakos IP
    J Cell Mol Med; 2019 Dec; 23(12):8010-8018. PubMed ID: 31568628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting lipid metabolism in multiple myeloma cells: Rational development of a synergistic strategy with proteasome inhibitors.
    Xu G; Huang S; Peng J; Gao X; Li M; Yu S; Liu Z; Qie P; Wang Y; Yu S; Liu S; Wen H; Su L; Li P; Guang B; Dong R; Liu J; Yang T
    Br J Pharmacol; 2021 Dec; 178(23):4741-4757. PubMed ID: 34378191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global cellular response to chemotherapy-induced apoptosis.
    Wiita AP; Ziv E; Wiita PJ; Urisman A; Julien O; Burlingame AL; Weissman JS; Wells JA
    Elife; 2013 Oct; 2():e01236. PubMed ID: 24171104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAG3 induction is required to mitigate proteotoxicity via selective autophagy following inhibition of constitutive protein degradation pathways.
    Rapino F; Jung M; Fulda S
    Oncogene; 2014 Mar; 33(13):1713-24. PubMed ID: 23644654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.
    Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A
    Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis.
    Besse L; Besse A; Mendez-Lopez M; Vasickova K; Sedlackova M; Vanhara P; Kraus M; Bader J; Ferreira RB; Castellano RK; Law BK; Driessen C
    Haematologica; 2019 Sep; 104(9):e415-e419. PubMed ID: 30792209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.